| Literature DB >> 34257844 |
Emily Amor Stander1, Thomas Dugé de Bernonville1, Nicolas Papon2, Vincent Courdavault1.
Abstract
Camptothecin is a clinically important monoterpene indole alkaloid (MIAs) used for treating various cancers. Currently, the production of this biopharmaceutical hinges on its extraction from camptothecin-producing plants, leading to high market prices and supply bottlenecks. While synthetic biology combined with metabolic approaches could represent an attractive alternative approach to manufacturing, it requires firstly a complete biosynthetic pathway elucidation, which is, unfortunately, severely missing in species naturally accumulating camptothecin. This knowledge gap can be attributed to the lack of high-quality genomic resources of medicinal plant species. In such a perspective, Yamazaki and colleagues produced the first described and experimentally validated chromosome-level plant genome assembly of Ophiorrhiza pumila, a prominent source plant of camptothecin for the pharmaceutical industry. More specifically, they have developed a method incorporating Illumina reads, PacBio single-molecule reads, optical mapping and Hi-C sequencing, followed by the experimental validation of contig orientation within scaffolds, using fluorescence in situ hybridization (FISH) analysis. This relevant strategy resulted in the most contiguous and complete de novo plant reference genome described to date, which can streamline the sequencing of new plant genomes. Further mining approaches, including integrative omics analysis, phylogenetics, gene cluster evaluation and comparative genomics were successfully used to puzzle out the evolutionary origins of MIA metabolism and revealed a short-list of high confidence MIA biosynthetic genes for functional validation.Entities:
Keywords: Biosynthetic pathway; Genome mining; Medicinal plants; Next-generation sequencing; Pharmaceuticals; Synthetic biology
Year: 2021 PMID: 34257844 PMCID: PMC8254074 DOI: 10.1016/j.csbj.2021.06.028
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Fig. 1The astounding assortment of MIAs found in some prominent medicinal plants. MIAs are mainly derived from a single common intermediate, strictosidine, which is the product of the condensation reaction between tryptamine (derived from the decarboxylation of tryptophan by TDC) and secologanin (derived from the iridoid pathway). TDC: tryptophan decarboxylase, STR: strictosidine synthase.
Fig. 2Sequential multistage genome scaffolding strategy. This combines 2nd generation (green), 3rd generation- (purple), and scaffolding technologies (orange), to generate the chromosome-level O. pumila reference genome assembly. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 3The biocomputational methodologies that were integrated into this study included. A) Phylogeny, B) Biosynthetic Gene Clusters, C) Synteny and collinearity analysis across different MIA-producing species, and D) gene-metabolite correlation networks.